Condition : Healthy Subjects
Interventions : Drug: IONIS-ENaCRx; Drug: Placebo
Sponsor : Ionis Pharmaceuticals, Inc.
A Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of IONIS-ENaCRx in Healthy Volunteers and Patients With Cystic Fibrosis
Mon, 27 Aug 2018 12:00:00 EDT
Last Update Posted: 03/08/19 11:56AM